EGF and breast cancer: A highly invasive and metastatic human breast cancer cell line, MDA-MB-231, was used because of the extent of characterization of this cell line [14], including its migration behavior in the presence of EGF or SDF-1α gradients using conventional Boyden chamber [12], [14], [31].